Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
ScienceRise: Pharmaceutical Science is Scopus-indexed (Q3, CiteScore 1.6). Published by Technology Center.
Checked against the index lists dated .
ISSN 2519-4844Verify ISSN ↗2519-4852Verify ISSN ↗
Publisher: Technology Center
Cost to publish: About US$53 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 48 / 79 | 39th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q3, CiteScore 1.6.
ScienceRise: Pharmaceutical Science is Q3 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 48 of 79), by CiteScore 2025.
ScienceRise: Pharmaceutical Science is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.6, quartile Q3, 39th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.200, quartile Q3, with an H-index of 10.
The publisher lists an article processing charge of about US$53 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
ScienceRise: Pharmaceutical Science is published by Technology Center. Its print ISSN is 2519-4844 and its online ISSN is 2519-4852.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
ScienceRise: Pharmaceutical Science has an h-index of 10 and a 2-year mean of 0.68 citations per paper (OpenAlex). Its Scopus CiteScore is 1.6, quartile Q3. On 2-year citations it ranks #52 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
ScienceRise: Pharmaceutical Science published 59 papers in 2025; its busiest recent year was 2024 with 64. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from Ukraine (66.8%), Uzbekistan (5.6%) and Indonesia (4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.